GL1X · GenesisL1 explorer

MolNFT v1 · #90595 · protein

Structure of human ceruloplasmin at 2.6 a resolution

4ENZ: “Structure of human ceruloplasmin at 2.6 a resolution”. X-ray diffraction, 6 ligands (NAG, CU, CA), 14 pockets (best druggability 0.85). MolNFT v1 #90595 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4ENZ
Type
protein
Length
1,029 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ceruloplasmin
EC
1.16.3.1
UniProt
P00450
Ligands
NAG, CU, CA, NA, O, OXY
Pockets
14 · best druggability 0.85

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACeruloplasmin (EC 1.16.3.1)protein102914% helix, 39% strandP00450

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
  • CU · Copper (II) ion · metal · 6 copies · chains A
  • CA · Calcium ion · metal · chains A
  • NA · Sodium ion · metal · chains A
  • O · Oxygen atom · ion · chains A
  • OXY · Oxygen molecule · ion · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16290.850.9061GOL
26020.690.7889empty
33380.620.7949empty
42390.620.8130empty
51290.530.8120empty

Modifications

Observed in the structure: 5 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 4ENZ · Structure of human ceruloplasmin at 2.6 A resolution · the same entry in another collection · chain A against A, TM-score 1.00
  • P00450 · AlphaFold monomer V2.0 prediction for ceruloplasmin (P00450) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.